NCT03667651View on ClinicalTrials.gov

The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
EczemaAsthmaAllergy;Food
Interventions
DRUG

EpiCeram

Parents will be instructed to apply EpiCeram™ to the full skin surface of their child twice per day for six months.

Trial Locations (4)

3052

Frances Perry Private Hospital, Parkville

Murdoch Children's Research Institute, Parkville

Royal Women's Hospital, Parkville

3084

Mercy Women's Hospital, Heidelberg

All Listed Sponsors
lead

University of Melbourne

OTHER